Position
Optas, LLC in AbbVie Inc.
Back to the book · All holders of ABBV
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$76.9K$228.49 → $217.49
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.99K | $1.6M | — | — | — | 0.3% |
| Q1 2026 | 7.57K | $1.65M | $217.49 | −$76.9K | $125.3K | 0.2% |